A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study

Abstract

Purpose: To compare the long-term survival outcomes and acute toxicity between locoregionally advanced nasopharyngeal carcinoma (NPC) patients who received either weekly or 3-weekly cisplatin during concurrent chemoradiotherapy (CCRT). Methods: Between November 2008 and August 2011, 241 biopsy-proved NPC patients receiving concurrent cisplatin with… (More)
DOI: 10.7150/jca.21357

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Meng2018ACO, title={A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study}, author={Dong-Fang Meng and Rui Sun and Li-xia Peng and You-sheng Huang and Qin Yang and Dong-hua Luo and Wei-Han Hu and F. Xie and Wei Luo and Chong Zhao and Ling Guo and Hai-qiang Mai and Ming-yuan Chen and Ping Xie and Li-sheng Zheng and Jun-Ping Yang and Yan Mei and Yuan-Yuan Qiang and Liang Xu and Chang-Zhi Li and Bi-jun Huang and Chao-nan Qian}, booktitle={Journal of Cancer}, year={2018} }